Ulrich Kilian

Title: Ulrich Kilian: Innovator in Respiratory Treatment

Introduction

Ulrich Kilian is a notable inventor based in Reichenau, Germany. He has made significant contributions to the field of respiratory medicine, holding a total of five patents. His work focuses on innovative treatments that enhance patient care and improve health outcomes.

Latest Patents

Kilian's latest patents include a synergistic combination for the treatment of respiratory tract disorders. This invention relates to the combined administration of PDE inhibitors and β-adrenoceptor agonists. Another significant patent involves a synergistic combination comprising roflumilast and a PDE-3 inhibitor. This patent discloses the use of the PDE inhibitor N-(3,5-dichloropyrid-4-yl)-3-cyclopropylmethoxy-4-difluoromethoxy benzamide, along with a pharmacologically tolerable salt or N-oxide thereof, for inhibiting bronchospasms and treating conditions such as acute obstructive bronchitis, asthma, or COPD.

Career Highlights

Throughout his career, Ulrich Kilian has worked with prominent companies in the pharmaceutical industry. Notable among these are Altana Pharma AG and Byk Gulden Lomberg Chemische Fabrik GmbH. His experience in these organizations has contributed to his expertise in developing innovative treatments.

Collaborations

Kilian has collaborated with esteemed colleagues, including Christian Schudt and Gerhard Grundler. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking medical solutions.

Conclusion

Ulrich Kilian's contributions to respiratory treatment through his patents and collaborations highlight his role as an influential inventor in the medical field. His work continues to pave the way for advancements in patient care and treatment options.